The future of atrial fibrillation management: integrated care and stratified therapy

Atrial Fibrillation

Integrated Care in Atrial Fibrillation: A Road Map to the Future

Circ Cardiovasc Qual Outcomes

Bhat A, Khanna S, Chen HHL, Gupta A, Gan GCH, Denniss AR, MacIntyre CR, Tan TC

doi: 10.1161/CIRCOUTCOMES.120.007411

Atrial Fibrillation

Integrated Management Program Advancing Community Treatment of Atrial Fibrillation (IMPACT-AF): A cluster randomized trial of a computerized clinical decision support tool

Am Heart J.

Cox JL, Parkash R, Foster GA, Xie F, MacKillop JH, Ciaccia A, Choudhri SH, Hamilton LM, Nemis-White JM, Thabane L, IMPACT-AF Investigators.

doi: 10.1016/j.ahj.2020.02.019.

Atrial Fibrillation

Early Rhythm-Control Therapy in Patients with Atrial Fibrillation

N Engl J Med.

Kirchhof P, Camm AJ, Goette A, Brandes A, Eckardt L, Elvan A, Fetsch T, van Gelder IC, Haase D, Haegeli LM, Hamann F, Heidbüchel H, Hindricks G, Kautzner J, Kuck KH, Mont L, Ng GA, Rekosz J, Schoen N, Schotten U, Suling A, Taggeselle J, Themistoclakis S, Vettorazzi E, Vardas P, Wegscheider K, Willems S, Crijns HJGM, Breithardt G, EAST-AFNET 4 Trial Investigators

doi: 10.1056/NEJMoa2019422.

Atrial FibrillationThrombosis and StrokeTherapy and Intervention

Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation

N Engl J Med.

Cannon CP, Bhatt DL, Oldgren J, Lip GYH, Ellis SG, Kimura T, Maeng M, Merkely B, Zeymer U, Gropper S, Nordaby M, Kleine E, Harper R, Manassie J, Januzzi JL, Ten Berg JM, Steg PG, Hohnloser SH; RE-DUAL PCI Steering Committee and Investigators

doi: 10.1056/NEJMoa1708454.

Atrial Fibrillation

Improving Atrial Fibrillation Therapy: Is There a Gene for That?

J Am Coll Cardiol.

Hucker WJ, Hanley A, Ellinor PT

doi: 10.1016/j.jacc.2017.02.043.

Atrial FibrillationThrombosis and StrokeTherapy and Intervention

Cerebral Amyloid Angiopathy: Diagnosis, Clinical Implications, and Management Strategies in Atrial Fibrillation

J Am Coll Cardiol.

DeSimone CV, Graff-Radford J, El-Harasis MA, Rabinstein AA, Asirvatham SJ, Holmes DR Jr

doi: 10.1016/j.jacc.2017.07.724.

Atrial FibrillationHeart FailureLipid-Lowering Drugs

Targeted therapy of underlying conditions improves sinus rhythm maintenance in patients with persistent atrial fibrillation: results of the RACE 3 trial

Eur Heart J.

Rienstra M, Hobbelt AH, Alings M, Tijssen JGP, Smit MD, Brügemann J, Geelhoed B, Tieleman RG, Hillege HL, Tukkie R, Van Veldhuisen DJ, Crijns HJGM, Van Gelder IC; RACE 3 Investigators

doi: 10.1093/eurheartj/ehx739.

Atrial FibrillationThrombosis and Stroke

Association of Burden of Atrial Fibrillation With Risk of Ischemic Stroke in Adults With Paroxysmal Atrial Fibrillation: The KP-RHYTHM Study

JAMA Cardiol.

Go AS, Reynolds K, Yang J, Gupta N, Lenane J, Sung SH, Harrison TN, Liu TI, Solomon MD

doi: 10.1001/jamacardio.

Atrial FibrillationThrombosis and StrokeTherapy and Intervention

Economic Analysis of Apixaban Therapy for Patients With Atrial Fibrillation From a US Perspective: Results From the ARISTOTLE Randomized Clinical Trial

JAMA Cardiol.

Cowper PA, Sheng S, Lopes RD1, Anstrom KJ, Stafford JA, Davidson-Ray L, Al-Khatib SM, Ansell J, Dorian P, Husted S, McMurray JJ, Steg PG, Alexander JH, Wallentin L, Granger CB, Mark DB

doi: 10.1001/jamacardio.

Related content

Integrated Care in Atrial Fibrillation: A Road Map to the Future

Integrated Management Program Advancing Community Treatment of Atrial Fibrillation (IMPACT-AF): A cluster randomized trial of a computerized clinical decision support tool

Early Rhythm-Control Therapy in Patients with Atrial Fibrillation

Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation

Improving Atrial Fibrillation Therapy: Is There a Gene for That?

Cerebral Amyloid Angiopathy: Diagnosis, Clinical Implications, and Management Strategies in Atrial Fibrillation

Targeted therapy of underlying conditions improves sinus rhythm maintenance in patients with persistent atrial fibrillation: results of the RACE 3 trial

Association of Burden of Atrial Fibrillation With Risk of Ischemic Stroke in Adults With Paroxysmal Atrial Fibrillation: The KP-RHYTHM Study

Economic Analysis of Apixaban Therapy for Patients With Atrial Fibrillation From a US Perspective: Results From the ARISTOTLE Randomized Clinical Trial